AXID (2020-04-29)
- Starting date:
- April 29, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72959
Last updated: 2020-05-04
Summary
-
Product:
AXID 150 mg Capsules
Reason
Presence of N-nitrosodimethylamine (NDMA) near the interim acceptable concentration limit in affected lots
Depth of distribution
Wholesalers, Retailers, Healthcare establishments
Affected products
AXID 150 mg Capsules
DIN, NPN, DIN-HIM
DIN 00778338
Dosage form
Capsule
Strength
Nizatidine 150 mg
Lot or serial number
616927, 617088
Companies
- Recalling Firm
-
Pendopharm Division of Pharmascience Inc.
SUITE 100 6111, Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pendopharm Division of Pharmascience Inc.
SUITE 100 6111, Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA